0001209191-14-066728.txt : 20141105 0001209191-14-066728.hdr.sgml : 20141105 20141105172419 ACCESSION NUMBER: 0001209191-14-066728 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141103 FILED AS OF DATE: 20141105 DATE AS OF CHANGE: 20141105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACHS BRUCE I CENTRAL INDEX KEY: 0001197036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141197877 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-11-03 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197036 SACHS BRUCE I C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2014-11-03 4 M 0 20000 34.32 A 41210 D Common Stock 2014-11-03 4 S 0 17316 112.03 D 23894 D Common Stock 2014-11-03 4 S 0 2684 112.80 D 21210 D Common Stock 2014-11-04 4 M 0 10000 29.84 A 31210 D Common Stock 2014-11-04 4 S 0 2300 112.47 D 28910 D Common Stock 2014-11-04 4 S 0 3200 113.47 D 25710 D Common Stock 2014-11-04 4 S 0 4400 114.23 D 21310 D Common Stock 2014-11-04 4 S 0 100 115.45 D 21210 D Common Stock 2014-11-05 4 M 0 100 29.84 A 21310 D Common Stock 2014-11-05 4 S 0 100 111.86 D 21210 D Stock Option (right to buy) 34.32 2014-11-03 4 M 0 20000 0.00 D 2016-05-31 Common Stock 20000 0 D Stock Option (right to buy) 29.84 2014-11-04 4 M 0 10000 0.00 D 2017-05-31 Common Stock 10000 10000 D Stock Option (right to buy) 29.84 2014-11-05 4 M 0 100 0.00 D 2017-05-31 Common Stock 100 9900 D Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $112.03 (range $111.64 to $112.63). Open market sales reported on this line occurred at a weighted average price of $112.80 (range $112.64 to $113.24). Open market sales reported on this line occurred at a weighted average price of $112.47 (range $111.91 to $112.89). Open market sales reported on this line occurred at a weighted average price of $113.47 (range $112.91 to $113.88). Open market sales reported on this line occurred at a weighted average price of $114.23 (range $113.95 to $114.71). Fully vested. Omar White, Attorney-In-Fact 2014-11-05